Recipharm AB: Invitation to Presentation of Recipharm’s Interim Report for the First Quarter on 7 May 2015

Regulatory News:

Recipharm will publish its interim report for January-March 2015 on 7 May at 07:45 am CET.

The company invites investors, analysts and media to a web conference (in English) on 7 May at 10:00 am CET, where CEO Thomas Eldered and CFO Björn Westberg will present and comment on the report as well as answer questions.

The report will be available on Recipharm’s website www.recipharm.com/en/investors from 07:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 7 May.

To participate in the web conference, please use the below link: http://edge.media-server.com/m/p/hfsw4kpp

Questions may be submitted by dialing below telephone numbers or by typing them in the Q&A box during the conference. If you don’t wish to ask questions by telephone you only need to participate through the link above.

From Sweden: + 46 8 505 56 453
From Denmark: + 45 35 44 55 74
From Finland: + 358 9 8171 0490
From Norway: + 47 235 00 251
From the UK: + 44 203 009 24 55
From Germany: +49 211 971 900 76
From Switzerland: +41 225 80 29 94
From France: + 33 170750706
From Spain: +34 911 140 089
From Portugal: +35 121 06 09 104 
From USA: +1 855 228 3719 

Pin code for participants: 213122#

For questions about participation in the event, please contact: Linda Holmström, Brand & Communications Manager, + 46 8 602 45 13, linda.holmstrom@recipharm.com

Recipharm AB (publ)
Corporate identity number 556498-8425
Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52 00, Fax 46 8 81 87 03
www.recipharm.com

This information was brought to you by Cision http://news.cision.com